SE0102892D0 - Antivirals I - Google Patents

Antivirals I

Info

Publication number
SE0102892D0
SE0102892D0 SE0102892A SE0102892A SE0102892D0 SE 0102892 D0 SE0102892 D0 SE 0102892D0 SE 0102892 A SE0102892 A SE 0102892A SE 0102892 A SE0102892 A SE 0102892A SE 0102892 D0 SE0102892 D0 SE 0102892D0
Authority
SE
Sweden
Prior art keywords
antivirals
indanolamine
valinamide
hydroxy
compounds
Prior art date
Application number
SE0102892A
Other languages
English (en)
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Priority to SE0102892A priority Critical patent/SE0102892D0/sv
Publication of SE0102892D0 publication Critical patent/SE0102892D0/sv
Priority to JP2003523202A priority patent/JP2005501118A/ja
Priority to IL16062602A priority patent/IL160626A0/xx
Priority to CA002458040A priority patent/CA2458040A1/en
Priority to EP02763160A priority patent/EP1421060A1/en
Priority to PCT/SE2002/001549 priority patent/WO2003018537A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
SE0102892A 2001-08-29 2001-08-29 Antivirals I SE0102892D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0102892A SE0102892D0 (sv) 2001-08-29 2001-08-29 Antivirals I
JP2003523202A JP2005501118A (ja) 2001-08-29 2002-08-29 抗ウイルス性プロテアーゼインヒビター
IL16062602A IL160626A0 (en) 2001-08-29 2002-08-29 Antiviral protease inhibitors
CA002458040A CA2458040A1 (en) 2001-08-29 2002-08-29 Antiviral protease inhibitors
EP02763160A EP1421060A1 (en) 2001-08-29 2002-08-29 Antiviral protease inhibitors
PCT/SE2002/001549 WO2003018537A1 (en) 2001-08-29 2002-08-29 Antiviral protease inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102892A SE0102892D0 (sv) 2001-08-29 2001-08-29 Antivirals I

Publications (1)

Publication Number Publication Date
SE0102892D0 true SE0102892D0 (sv) 2001-08-29

Family

ID=20285183

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102892A SE0102892D0 (sv) 2001-08-29 2001-08-29 Antivirals I

Country Status (6)

Country Link
EP (1) EP1421060A1 (sv)
JP (1) JP2005501118A (sv)
CA (1) CA2458040A1 (sv)
IL (1) IL160626A0 (sv)
SE (1) SE0102892D0 (sv)
WO (1) WO2003018537A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013386726B2 (en) * 2013-04-18 2019-08-01 Xi'an Libang Pharmaceutical Technology Co., Ltd. Use of 7-alpha-[9-(4,4,5,5,5 - pentafluoro-pentyl-sulfinyl)nonyl]-estra-1,3,5(10)-triene-3,17beta-diol and derivatives thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701245D0 (sv) * 1997-04-04 1997-04-04 Bjoern Classon Antivirals

Also Published As

Publication number Publication date
CA2458040A1 (en) 2003-03-06
IL160626A0 (en) 2004-07-25
JP2005501118A (ja) 2005-01-13
EP1421060A1 (en) 2004-05-26
WO2003018537A1 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
DE60022508D1 (de) Inhibitoren von serin proteasen
BR0111451A (pt) Inibidores de serina protease
ES2123065T3 (es) Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
TR200101899T2 (tr) Trombin inhibitörleri.
BR0209064A (pt) Hidroxamatos de alquila tricìclicos, sua preparaçãoe seu uso como inibidores de proliferação de células
TR200100605T2 (tr) Arilpiperazinler ve bunların metaloproteinaz inhibe edici maddeler (MMP) olarak kullanımı
DK1392666T3 (da) Biologisk aktive methylenblåt-derivater
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
PT1453512E (pt) Derivados de acetileno tendo actividade antagonistica do mglur 5
DE69907977D1 (de) Pyrrolobenzodiazepine
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
ATE154800T1 (de) N-(alkanoylamino-2-hydroxypropyl)-sulfonamide verwendbar als retrovirale proteaseninhibitoren
NZ331327A (en) Serine protease inhibitors having an acylguanidine side chain
DE60033689D1 (de) Inhibitoren von serinproteasen
DE60126978D1 (de) Inhibitoren von serin proteasen
BR9612360A (pt) Inibidores de amidino protease
TR200000272T2 (tr) Antitümör ve antimetastaz maddeleri olarak o-ikameli hidrosikumaranon türevleri.
BR0108240A (pt) Desidroaminoácidos
KR960701085A (ko) 단백 분해 효소 억제 활성을 지닌 펩티드 보론산 유도체(peptide boronic acid derivatives having protease inhibiting activity)
AU5970199A (en) Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
ATE258930T1 (de) Dihydrobenzifurane
ATE356114T1 (de) Inhibitoren von metalloproteinasen
SE0102892D0 (sv) Antivirals I
DK1244643T3 (da) Tryptaseinhibitorer